» Articles » PMID: 28493949

Prediction of Pancreatic Fistula After Pancreatoduodenectomy by Preoperative Dynamic CT and Fecal Elastase-1 Levels

Overview
Journal PLoS One
Date 2017 May 12
PMID 28493949
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To validate preoperative dynamic CT and fecal elastase-1 level in predicting the development of pancreatic fistulae after pancreatoduodenectomy.

Materials And Methods: For 146 consecutive patients, CT attenuation values of the nontumorous pancreatic parenchyma were retrospectively measured on precontrast, arterial and equilibrium phase images for calculation of enhancement ratios. CT enhancement ratios and preoperative fecal elastase-1 levels were correlated with the development of pancreatic fistulae using independent t-test, logistic regression models, ROC analysis, Youden method and tree analysis.

Results: The mean value of enhancement ratio on equilibrium phase was significantly higher (p = 0.001) in the patients without pancreatic fistula (n = 107; 2.26±3.63) than in the patients with pancreatic fistula (n = 39; 1.04±0.51); in the logistic regression analyses, it was significant predictor for the development of pancreatic fistulae (odds ratio = 0.243, p = 0.002). The mean preoperative fecal elastase-1 levels were higher (odds ratio = 1.003, p = 0.034) in the pancreatic fistula patients than other patients, but there were no significant differences in the areas under the curve between the prediction values of CT enhancement ratios and fecal elastase-1 combined and those of CT enhancement ratios alone (P = 0.897, p = 0.917) on ROC curve analysis. Tree analysis revealed that the CT enhancement ratio was more powerful predictor of pancreatic fistula than fecal elastase-1 levels.

Conclusion: The preoperative CT enhancement ratio of pancreas acquired at equilibrium phase regardless of combination with fecal elastase-1 levels might be a useful predictor of the risk of developing a pancreatic fistula following pancreatoduodenectomy.

Citing Articles

Risk stratification of postoperative pancreatic fistula and other complications following pancreatoduodenectomy. How far are we? A scoping review.

Alhulaili Z, Pleijhuis R, Hoogwater F, Nijkamp M, Klaase J Langenbecks Arch Surg. 2025; 410(1):62.

PMID: 39915344 PMC: 11802655. DOI: 10.1007/s00423-024-03581-9.


Radiological parameters to predict pancreatic texture: Current evidence and future perspectives.

Kalayarasan R, Himaja M, Ramesh A, Kokila K World J Radiol. 2023; 15(6):170-181.

PMID: 37424737 PMC: 10324497. DOI: 10.4329/wjr.v15.i6.170.


Do preoperative pancreatic computed tomography attenuation index and enhancement ratio predict pancreatic fistula after pancreaticoduodenectomy?.

Gnanasekaran S, Durgesh S, Gurram R, Kalayarasan R, Pottakkat B, Rajeswari M World J Radiol. 2022; 14(6):165-176.

PMID: 35978980 PMC: 9258308. DOI: 10.4329/wjr.v14.i6.165.


The usefulness of preoperative exocrine function evaluated by the C-trioctanoin breath test as a significant physiological predictor of pancreatic fistula after pancreaticoduodenectomy.

Kato H, Asano Y, Ito M, Kawabe N, Arakawa S, Shimura M BMC Surg. 2022; 22(1):49.

PMID: 35148748 PMC: 8832756. DOI: 10.1186/s12893-022-01500-7.


Preoperative Computed Tomography Imaging of the Pancreas Identifying Predictive Factors for the Progression of Grade A, or Biochemical Leak, to Grade B Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy: A Retrospective Study.

Liu F, Jiang X, Huang B, Yu Y Med Sci Monit. 2021; 27:e928489.

PMID: 33627617 PMC: 7923398. DOI: 10.12659/MSM.928489.


References
1.
Fletcher J, Wiersema M, Farrell M, Fidler J, Burgart L, Koyama T . Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology. 2003; 229(1):81-90. DOI: 10.1148/radiol.2291020582. View

2.
Marcus S, Cohen H, Ranson J . Optimal management of the pancreatic remnant after pancreaticoduodenectomy. Ann Surg. 1995; 221(6):635-45; discussion 645-8. PMC: 1234686. DOI: 10.1097/00000658-199506000-00003. View

3.
Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Nakagawa N . No mortality after 150 consecutive pancreatoduodenctomies with duct-to-mucosa pancreaticogastrostomy. J Surg Oncol. 2007; 97(3):205-9. DOI: 10.1002/jso.20903. View

4.
Richter A, Niedergethmann M, Sturm J, Lorenz D, Post S, Trede M . Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg. 2003; 27(3):324-9. DOI: 10.1007/s00268-002-6659-z. View

5.
Sato N, Yamaguchi K, Chijiiwa K, Tanaka M . Risk analysis of pancreatic fistula after pancreatic head resection. Arch Surg. 1998; 133(10):1094-8. DOI: 10.1001/archsurg.133.10.1094. View